Click a link below to view the mailing archive as if it had been sent to you.
| 2016-08-31 12:15 | | Amgen, Inc: How Damaging Will Be Novartis’ Enbrel Copy and more... |
| 2016-08-31 00:15 | | Novartis pays to settle illegal shipping allegations and more... |
| 2016-08-30 12:15 | | California court hangs out a welcome sign: Drug makers can be sued here and more... |
| 2016-08-30 00:15 | | Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting and more... |
| 2016-08-29 12:15 | | Pharma's reputation takes another hit with Mylan's Epipen pricing debacle and more... |
| 2016-08-28 12:15 | | Is Mylan on its Way to Being the New Valeant? and more... |
| 2016-08-27 12:15 | | Mallinckrodt sharpens specialty pharma focus and more... |
| 2016-08-27 00:15 | | Will AstraZeneca plc (ADR) Survive Crestor Patent Expiration? and more... |
| 2016-08-26 12:15 | | Amid layoff fears, AstraZeneca stakes a ‘For Sale’ sign on US campus and more... |
| 2016-08-26 00:15 | | Specialty pharma working to bring EpiPen competitor to market and more... |
| 2016-08-25 12:15 | | Under fire, Mylan takes steps to make $600 EpiPen more affordable and more... |
| 2016-08-25 00:15 | | Turing exec claims she was sexually assaulted by company co-founder and more... |
| 2016-08-24 12:15 | | AstraZeneca to sell molecule antibiotics business to Pfizer and more... |
| 2016-08-24 00:15 | | Valeant Pharmaceuticals Intl Inc (VRX): Can New CFO Help Turn the Company Around and more... |
| 2016-08-23 12:15 | | 4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss and more... |
| 2016-08-23 00:15 | | Pfizer's Medivation buy seen prescribing more biotech M&A and more... |
| 2016-08-22 12:15 | | A biotech firm, on the brink of ruin, resurrects itself via man — and microbe and more... |
| 2016-08-22 00:15 | | Why Did Mylan Hike EpiPen Prices 400%? Because They Could and more... |
| 2016-08-21 00:15 | | Who Is Driving Pfizer's Management Team? (PFE) and more... |
| 2016-08-19 12:15 | | Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp. and more... |
| 2016-08-19 00:15 | | How Much Medivation Can Really Fetch in a Buyout and more... |
| 2016-08-18 12:15 | | Medivation shares pop after report that at least five companies interested in deal and more... |
| 2016-08-18 00:15 | | GSK enters pay-for-performance deal for gene therapy and more... |
| 2016-08-17 12:15 | | Why Big Pharma Gets A Failing Grade On Clinical Trial Transparency and more... |
| 2016-08-17 00:15 | | Biotech CEO confidence returns, but deal landscape still seen as bleak and more... |
| 2016-08-16 12:15 | | OncoGenex scrambles after trial fail and more... |
| 2016-08-16 00:15 | | Why CRISPR Is An Attractive Approach To Treat Sickle Cell Disease and more... |
| 2016-08-15 12:15 | | Allergan to consolidate operations in NJ and more... |
| 2016-08-15 00:15 | | Regulatory Explainer: Everything You Need to Know About Biosimilars and more... |
| 2016-08-14 00:15 | | In the Spirit of the Olympics: On and Off the Pharma Podium and more... |
| 2016-08-13 00:15 | | CRISPR patent fight: The legal bills are soaring and more... |
| 2016-08-12 12:15 | | Clinton and Trump are both wrong about Medicare’s ability to negotiate drug prices and more... |
| 2016-08-12 00:15 | | Nonprofit seeks to dispel ‘myths’ about how it assesses drug values and more... |
| 2016-08-11 12:15 | | Cramer: Valeant Probe Is a Reminder of the Bristol-Myers Scandal and more... |
| 2016-08-11 00:15 | | Why certain drugs don't make the formulary and more... |
| 2016-08-10 12:15 | | Valeant salesforce stabilizes as Xifaxan rebounds and more... |
| 2016-08-10 00:15 | | Bristol-Myers Squibb Co (BMY): How Deep is the Opdivo Wound? and more... |
| 2016-08-09 12:15 | | Valeant Pharmaceuticals Intl Inc (VRX) Stock Surges on Healthy Outlook, Aggressive Turnaround Plans and more... |
| 2016-08-08 12:15 | | Experimental asthma pill from Novartis posts encouraging results and more... |
| 2016-08-07 00:15 | | Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche and more... |
| 2016-08-05 12:15 | | Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet and more... |
| 2016-08-05 00:15 | | Many pediatric clinical trials go unpublished or unfinished and more... |
| 2016-08-04 12:15 | | Will Merck Pay A 29% Premium for Biogen? and more... |
| 2016-08-03 12:15 | | Pfizer Breakup May Depend on Trump or Clinton Winning the Election and more... |
| 2016-08-03 00:15 | | Merck and Allergan have both expressed interest in a Biogen takeover |
| 2016-08-02 12:15 | | Pfizer Beats Estimates as New Cancer, Arthritis Drugs Grow and more... |
| 2016-08-02 00:15 | | Biotechs say that controversy over pricing is a bigger risk each year and more... |
| 2016-08-01 12:15 | | Pfizer Acquires Gene Therapy Firm Bamboo for $150 Million and more... |
| 2016-08-01 00:15 | | Evoke Pharma: Hop On And Ride The Elevator Higher and more... |
